tolvaptan has been researched along with Genetic Diseases, X-Chromosome Linked in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Garrahy, A; Hannon, AM; Thompson, CJ; Williams, DJ; Zia-Ul-Hussnain, HM | 1 |
Balla, A; Erdélyi, LS; Groß, U; Hunyady, L; Mann, WA; Morris-Rosendahl, DJ; Nagel, M; Várnai, P | 1 |
2 other study(ies) available for tolvaptan and Genetic Diseases, X-Chromosome Linked
Article | Year |
---|---|
Secondary resistance to tolvaptan in two patients with SIAD due to small cell lung cancer.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drug Resistance; Fatal Outcome; Female; Genetic Diseases, X-Linked; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma; Sodium; Tolvaptan; Vasopressins | 2018 |
Mutation in the V2 vasopressin receptor gene, AVPR2, causes nephrogenic syndrome of inappropriate diuresis.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Arrestins; Benzazepines; beta-Arrestins; Cell Membrane; Cyclic AMP; DNA Mutational Analysis; Dynamins; Endocytosis; Exons; Female; Genetic Diseases, X-Linked; HEK293 Cells; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Mutation; Pedigree; Receptors, Vasopressin; Tolvaptan | 2015 |